Hebbar M - Search Results

1

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.

Hebbar M, Adenis A, Révillion F, Duhamel A, Romano O, Truant S, Libersa C, Giraud C, Triboulet JP, Pruvot FR, Peyrat JP. Hebbar M, et al. Eur J Cancer. 2009 Jul;45(10):1871-6. doi: 10.1016/j.ejca.2009.03.011. Epub 2009 Apr 8. Eur J Cancer. 2009. PMID: 19361981

2

Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.

Hebbar M, Pruvot FR, Romano O, Triboulet JP, de Gramont A. Hebbar M, et al. Cancer Treat Rev. 2009 Dec;35(8):668-75. doi: 10.1016/j.ctrv.2009.08.005. Epub 2009 Sep 5. Cancer Treat Rev. 2009. PMID: 19733977 Review.

3

Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer.

Hebbar M, Wacrenier A, Desauw C, Romano O, Cattan S, Triboulet JP, Pruvot FR. Hebbar M, et al. Anticancer Drugs. 2006 Aug;17(7):855-7. doi: 10.1097/01.cad.0000217425.44584.9f. Anticancer Drugs. 2006. PMID: 16926635 Clinical Trial.

4

Significance of soluble endothelial molecule E-selectin in patients with breast cancer.

Hebbar M, Peyrat JP. Hebbar M, et al. Int J Biol Markers. 2000 Jan-Mar;15(1):15-21. doi: 10.1177/172460080001500103. Int J Biol Markers. 2000. PMID: 10763135 Free article.

5

KRAS mutational status assessment in patients with metastatic colorectal cancer: are the clinical implications so clear?

Hebbar M, Fournier P, Romano O. Hebbar M, et al. Eur J Cancer Care (Engl). 2010 Mar;19(2):167-71. doi: 10.1111/j.1365-2354.2009.01134.x. Epub 2009 Aug 20. Eur J Cancer Care (Engl). 2010. PMID: 19702696 Review.

6

Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients.

Revillion F, Hebbar M, Bonneterre J, Peyrat JP. Revillion F, et al. Among authors: hebbar m. Eur J Cancer. 1996 Feb;32A(2):231-4. doi: 10.1016/0959-8049(95)00568-4. Eur J Cancer. 1996. PMID: 8664033

7

Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

Hollebecque A, Bouché O, Romano O, Scaglia E, Cattan S, Zerbib P, Heurgue A, Lagarde S, Mariette C, Triboulet JP, Pruvot FR, Hebbar M. Hollebecque A, et al. Among authors: hebbar m. Chemotherapy. 2010;56(3):234-8. doi: 10.1159/000316848. Epub 2010 Jun 16. Chemotherapy. 2010. PMID: 20551640

8

High-dose FOLFIRI, surgery, and radiofrequency ablation for patients with unresectable liver metastases from colorectal cancer.

Hebbar M, Truant S, Desauw C, Sergent-Baudson G, Cattan S, Piessen G, Pruvot FR. Hebbar M, et al. Anticancer Res. 2013 Apr;33(4):1603-7. Anticancer Res. 2013. PMID: 23564804

9

Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens.

Truant S, Séquier C, Leteurtre E, Boleslawski E, Elamrani M, Huet G, Duhamel A, Hebbar M, Pruvot FR. Truant S, et al. Among authors: hebbar m. HPB (Oxford). 2015 Feb;17(2):176-84. doi: 10.1111/hpb.12316. Epub 2014 Jul 9. HPB (Oxford). 2015. PMID: 25041611 Free PMC article. Review.

10

Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.

Desurmont T, Skrypek N, Duhamel A, Jonckheere N, Millet G, Leteurtre E, Gosset P, Duchene B, Ramdane N, Hebbar M, Van Seuningen I, Pruvot FR, Huet G, Truant S. Desurmont T, et al. Among authors: hebbar m. Cancer Sci. 2015 Mar;106(3):262-9. doi: 10.1111/cas.12603. Epub 2015 Mar 5. Cancer Sci. 2015. PMID: 25580640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters